US waives tariff on specialty drugs from India and 19 countries
In short
The US said some specialty drugs and related ingredients from India and 19 other countries will not face tariffs.
This comes as the government prepares a 100% tariff on some patented drug imports from September 29. The report does not give the full list of covered products.
What the reporting says
The US said it will not charge tariffs on certain speciality drugs and associated ingredients imported from India and 19 other countries, according to reporting tied to the Federal Register. The exemption comes as the Commerce Department prepares to impose a 100% tariff on certain patented pharmaceutical imports and related ingredients from September 29, following a Trump proclamation. The immediate consequence is zero-tariff treatment for covered drugs, while the full list and downstream industry impact are not fully stated.
Why it matters
The Commerce Department published a country list in the Federal Register showing tariff relief for certain speciality drugs and ingredients from India and 19 other countries. This is set against a planned 100% tariff on certain patented pharmaceutical imports and associated ingredients from September 29. The effect is clear for covered shipments, but the full scope of products and business impact remains incomplete in the reporting.